Lilly: Taking the Fight to MDR-TB

Today's guest blog comes from Lilly's vice president of Global Health Programs, Evan Lee, M.D.

“Americans can no longer afford to be indifferent to the rise of drug-resistant tuberculosis.”

That’s the conclusion of an excellent op-ed in the International New York Times this week, penned by a journalist who recently visited Indonesia to investigate the impact of this disease. The country registers about 7,000 new cases of multidrug-resistant TB (MDR-TB) each year.

Read on for more about why even when the cost of medicine is free of charge, many don't complete the treatment.